Home›Search›Cardiovascular and Hematological Disorders - Drug Targets
Cardiovascular and Hematological Disorders - Drug Targets
Bentham Science Publishers · United Arab Emirates · Est. 2006
ISSN2212-4063
SJR Q3✓ Scopus / SJR
12
/ 100
High Risk
Score Breakdown
✓ Scopus Q3+12
Total12
Journal Impact Factor
Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.
SJR Score
0.235
H-Index
44
SNIP
0.278
Total Works
644
Total Citations
8,268
2yr Mean Citedness
0.85
Free JIF alternative
Aims & Scope✦ Compiled from public sources
Cardiovascular and Hematological Disorders - Drug Targets covers developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of molecular targets involved in cardiovascular and hematological disorders. It focuses on disease-specific proteins, receptors, enzymes, and genes.
AI-compiled from public web sources · verify on the publisher page
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
PharmacologyQ3
Cardiology and Cardiovascular MedicineQ4
HematologyQ4
Medicine (miscellaneous)Q4
Molecular MedicineQ4
Subject Classification
Scopus Categories
Molecular MedicinePharmacologyHematologyCardiology and Cardiovascular MedicineMedicine (miscellaneous)
Research Topics (OpenAlex)
Diverse Scientific and Economic StudiesAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesNatural Antidiabetic Agents StudiesLipoproteins and Cardiovascular HealthVenous Thromboembolism Diagnosis and ManagementDiabetes Treatment and ManagementAtherosclerosis and Cardiovascular DiseasesPlatelet Disorders and TreatmentsCardiovascular Function and Risk Factors